These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 4186331)

  • 1. Percutaneous absorption of Soman and Tabun, two organophosphorus cholinesterase inhibitors.
    Fredriksson T
    Acta Derm Venereol; 1969; 49(5):484-9. PubMed ID: 4186331
    [No Abstract]   [Full Text] [Related]  

  • 2. Hydrolysis of Soman and Tabun (two organophosphorus cholinesterase inhibitors) in cutaneous tissues.
    Fredriksson T
    Acta Derm Venereol; 1969; 49(5):490-2. PubMed ID: 4186332
    [No Abstract]   [Full Text] [Related]  

  • 3. [Reactivation of acetylcholinesterase and cholinesterase. Titrimetric studies on brain homogenate and plasma after in vitro inhibition by Tabun, Sarin and Soman].
    Back P
    Z Klin Chem Klin Biochem; 1969 May; 7(3):301-5. PubMed ID: 5356498
    [No Abstract]   [Full Text] [Related]  

  • 4. [Effect of cholinesterase inhibition on nicotinic effects of dicholine and monocholine esters of suberic acid in experiments on cats].
    Andrianova IP; Mikhel'son MIa; Mndzhoian OL; Protas LL
    Dokl Akad Nauk SSSR; 1976; 227(1):248-51. PubMed ID: 1269372
    [No Abstract]   [Full Text] [Related]  

  • 5. [Effect of some drugs with anticholinesterase action on muscular cholinesterases].
    Zakharova AV
    Vopr Med Khim; 1970; 16(1):19-23. PubMed ID: 5435382
    [No Abstract]   [Full Text] [Related]  

  • 6. Influence of solvents and surface active agents on the barrier function of the skin towards Sarin. 3. Restoration of the barrier function.
    Fredriksson T
    Acta Derm Venereol; 1969; 49(5):481-3. PubMed ID: 4186330
    [No Abstract]   [Full Text] [Related]  

  • 7. [Combined antidote therapy in experimental animals poisoned with Tabun, Sarin and Soman].
    Hildebrandt HJ
    Naunyn Schmiedebergs Arch Exp Pathol Pharmakol; 1969; 263(1):222-3. PubMed ID: 5804251
    [No Abstract]   [Full Text] [Related]  

  • 8. [Quaternary phosphonic salts as reversible cholinesterase inhibitors].
    Brestkin AP; Brovko VS; Zhukovskiĭ IuG; Kolchanova NA; Rozengart EV
    Dokl Akad Nauk SSSR; 1984; 277(3):735-7. PubMed ID: 6489118
    [No Abstract]   [Full Text] [Related]  

  • 9. [Study on antidote therapy of percutaneous organophosphate poisoning in rats].
    Oldiges H
    Arzneimittelforschung; 1971 Jul; 21(7):1028-30. PubMed ID: 5109489
    [No Abstract]   [Full Text] [Related]  

  • 10. [Role of ion interactions in cholinesterase inhibition].
    Kabachnik MI; Godovikov NN
    Dokl Akad Nauk SSSR; 1971 Jan; 196(2):348-51. PubMed ID: 5573199
    [No Abstract]   [Full Text] [Related]  

  • 11. [Kinetics of armin and phosphacol interaction with cholinesterases of different organs and tissues].
    Markov SM; Loshadkin NA; Imasheva MA
    Farmakol Toksikol; 1966; 29(1):72-6. PubMed ID: 5988621
    [No Abstract]   [Full Text] [Related]  

  • 12. [Role of substrate inhibition of myoneural junction acetylcholinesterase in the mechanism of the blocking action of irreversible cholinesterase inhibitors on neuromuscular behavior].
    Ivanov IuIa
    Dokl Akad Nauk SSSR; 1972 Feb; 202(6):1464-6. PubMed ID: 5012275
    [No Abstract]   [Full Text] [Related]  

  • 13. Interactions between sarin and the cholinergic antagonist PMCG in fast and slow skeletal muscle of the cat.
    Brimblecombe RW; Everett SD
    J Physiol; 1969 Jul; 203(1):19P-20P. PubMed ID: 5821873
    [No Abstract]   [Full Text] [Related]  

  • 14. [Differential influencing by paraoxon and Soman of single phrenic nerve fibers active in inspiration].
    Schmidt G; Sakai Y; Dal Ri H
    Naunyn Schmiedebergs Arch Pharmakol; 1970; 266(4):441-2. PubMed ID: 4253865
    [No Abstract]   [Full Text] [Related]  

  • 15. [The effect of tetanization of a skeletal muscle motor nerve on the blocking and anticholinesterase effect of armin and compound GD-42].
    Ivanov IuIa; Danilov AF; Zelikson BB; Mikhel'son MIa
    Farmakol Toksikol; 1972; 35(5):567-70. PubMed ID: 4652006
    [No Abstract]   [Full Text] [Related]  

  • 16. [The use of the multidimensional statistic analysis for investigation of anticholinesterase activity of organophosphorus inhibitors depending on their structure].
    Moralev SN; Baziukin AB
    Zh Evol Biokhim Fiziol; 1997; 33(3):302-7. PubMed ID: 9479389
    [No Abstract]   [Full Text] [Related]  

  • 17. [A trisubstituted derivative of orthophosphoric acid possessing powerful anticholinesterase activity].
    Olive G; Cheymol G
    Ann Pharm Fr; 1967 Nov; 25(11):679-82. PubMed ID: 5593164
    [No Abstract]   [Full Text] [Related]  

  • 18. Specific subsensitivity of the rat atrium to cholinergic drugs.
    Perrine SE; McPhillips JJ
    J Pharmacol Exp Ther; 1970 Nov; 175(2):496-502. PubMed ID: 5481713
    [No Abstract]   [Full Text] [Related]  

  • 19. Selective, near-total, irreversible inactivation of peripheral pseudocholinesterase and acetylcholinesterase in cats in vivo.
    Koelle GB; Davis R; Diliberto EJ; Koelle WA
    Biochem Pharmacol; 1974 Jan; 23(2):175-88. PubMed ID: 4360344
    [No Abstract]   [Full Text] [Related]  

  • 20. [Enzymatic identification of cholinesterase inhibitors].
    Nikol'skaia EB; Moralev SN
    Zh Evol Biokhim Fiziol; 1997; 33(3):274-9. PubMed ID: 9479388
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.